首页|我院2021~2022年药品不良反应分析报告

我院2021~2022年药品不良反应分析报告

扫码查看
目的 分析我院2021~2022 年的药品不良反应分析报告,旨在完善ADR监测工作的开展,并为患者用药安全提供参考.方法 调取我院 2021~2022 年的药品不良反应报告按患者基本情况、给药途径、药物品种、不良反应类型、严重程度、是否在新药监测期、上报人职业等多项内容进行汇总统计分析.结果 549 例报告中,医生上报的份数最多,306 例(55.74%);女性与男性例数相近;50~65 岁人群易发生药品不良反应,211 例(38.43%);静脉滴注给药药品不良反应最多,298 例(54.28%);抗肿瘤药不良反应例数居首,87 例(15.85%);皮肤及其附件损害最多,136 例(24.77%),其中严重例数最多的为血液系统损害,74 例(13.48%);新药监测期内不良反应发生最多的为卡瑞利珠单抗,11 例(34.38%).结论 通过定期培训宣传,提高全院医务人员对ADR的主动监测意识.重点加强中老年患者、抗肿瘤用药、新药监测期内药品的ADR监护,保障患者的药物治疗安全.
Adverse Drug Reactions Analysis Report of a Hospital in 2021~2022
OBJECTIVE To analyze the adverse drug reaction analysis reports of our hospital from 2021 to 2022,in order to improve the development of ADR monitoring and provide reference for the drug safety of pa-tients.METHODS Adverse drug reaction reports of our hospital from 2021 to 2022 were collected and analyzed statistically according to the basic situation of patients,routes of administration,varieties of drugs,types of adverse re-actions,severity,whether they were in the new drug monitoring period,occupation of the reporter,etc.RESULTS Among the 549 cases reported,306 cases(55.74%)were reported by doctors.The number of female and male cases is similar;There were 211 cases(38.43%)of adverse drug reactions in people aged 50-65 years.The most adverse drug reactions were caused by intravenous infusion,298 cases(54.28%).The number of adverse reactions of antitu-mor drugs was the first,87 cases(15.85%).The skin and its appendages were the most damaged,136 cases(24.77%),among which the most serious cases were blood system damage,74 cases(13.48%).The most adverse reactions occurred in new drug carrilizumab,11 cases(34.38%).CONCLUSION Through regular training and publicity,the awareness of active monitoring of ADR among all medical staff in the hospital can be improved.Focus on strengthening the ADR monitoring of middle-aged and elderly patients,anti-tumor drugs,and new drugs during the monitoring period to ensure the safety of drug treatment for patients.

Adverse drug reactionsNew drug monitoringRational drug useDrug safety

洪宝慧、陈荣

展开 >

福建省三明市第二医院,药学部,福建永安 366000

福建省三明市第二医院,麻醉科,福建永安 366000

药品不良反应 新药监测 合理用药 用药安全

2024

海峡药学
中国药学会福建分会

海峡药学

影响因子:0.643
ISSN:1006-3765
年,卷(期):2024.36(2)
  • 12